Fundraising FoxPathway to Cures — Full Portfolio
7 tracked investments · listed companies and verified rows first
Afimmune develops new medicines for rare and inflammatory diseases through drug discovery and development programs at various clinical and pre-clinical stages.
BiotechMedical DevicesDublin, IE
SeraGene Therapeutics is a pre-clinical stage biotech company developing RNA (siRNA) and nanomedicine-based therapies for coagulation disorders, including rare bleeding disorders, platelet dysfunction, and thrombotic disorders.
BiotechLongevity
Co-investorsForesite Capital
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics.
BiotechDigital HealthHardwareHealthtechMedical DevicesDallas, US
Daniel Powell(President & Chief Executive Officer)inAlejandro Covalin(Chief Technology Officer)inNavid Khodaparast(Chief Science Officer)inTed Costopoulos(Director)Carl R. Deeley(Director)
Co-investorsAggie Angel NetworkWave Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
<UNKNOWN>AnvesanaBE BiopharmaSeawolf Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.